Healthtech Startups

Onoco is an app that helps parents and childcare providers track infant routines, development milestones, and activities during the first five years of life. It enables secure sharing of information between parents and nannies, daycare centers, or other caregivers to ensure consistent care and monitoring of developmental progress.

1 investor

Onos provides AI-powered utilization management software for behavioral health payers, automating clinical authorization reviews by extracting clinical data across fragmented systems and applying automated decision support against plan guidelines. The platform consolidates prior authorization workflows to reduce administrative burden while enabling faster, quality-focused clinical decisions.

1 investor

OnPoint Vision designs, develops, and manufactures intraocular lenses (the AccuraSee IOPCL) that correct residual refractive error in patients who have already undergone cataract surgery, with additional focus on patients experiencing vision decline from age-related retinal conditions such as macular degeneration. The company's minimally-invasive implantable lens targets the ophthalmic and vision-correction medical device market.

1 investor

Onpoint Healthcare Partners offers Iris, a Medical Agent AI platform that autonomously handles administrative and operational healthcare workflows—including charting, coding, care management, and care coordination—using an AI plus expert-in-the-loop model. It serves hospitals, clinics, and private practices, integrating with EHR systems to reduce provider administrative burden and support revenue integrity.

1 investor

Onrise provides mental health services for student-athletes at NCAA member schools, including clinician-backed peer support, therapy, psychiatry, and crisis intervention designed to meet the association's four mental health best practices.

1 investor

Onsurity offers a monthly-subscription employee healthcare membership that bundles group health insurance, personal accident and term life cover, doctor consults, lab tests and wellness support for businesses across India. It serves HR and finance teams managing employee benefits and operates as an IRDAI-registered corporate agent.

1 investor

OnTimeTrials provides an AI platform that gives pharmaceutical sponsors visibility, predictability, and collaboration across clinical trials managed by multiple contract research organizations. The platform sits above fragmented CRO systems to restore real-time monitoring at portfolio, study, and site levels without workflow changes or heavy integrations.

1 investor

OnTracx offers a platform that applies recent scientific research to support the rehabilitation of runners with overuse injuries, measuring the actual load of each step and generating individualized return-to-run plans with remote field follow-up. It is aimed at healthcare professionals and clinics seeking to integrate running-injury rehabilitation into their existing practice.

1 investor

Onward provides transportation ordering and management software for healthcare facilities, along with an assisted door-through-door rideshare service called Companion Rides for patients and caregivers who need medical or non-emergency transportation.

1 investor

ONWARD Medical develops non-invasive and investigational spinal cord stimulation therapies to restore hand sensation, strength, and function in people with spinal cord injury. Its FDA-cleared, CE-marked medical devices are used by rehabilitation professionals in clinics and by patients at home.

1 investor

ONYA Therapeutics develops investigational pharmaceutical treatments for chronic and acute wounds, using a patented silicone-based patch that stabilises and delivers a well-characterised active compound to modulate wound exudate and restart healing. Its lead programme OTX-PP01 targets chronic wounds such as diabetic foot ulcers, with additional variants planned for battlefield trauma and cancer-related wounds.</parameter> <parameter name="founders">[{"full_name": "Thomas Hafner", "title": "CEO & Founder"}]

1 investor

Oona Health is a health insurance provider that offers medical counselling, timely treatment and prevention to improve customers' quality of life and ability to work. It serves companies and their employees, and operates alongside a treatment-provider network and a digital health offering.

1 investor

OnTop-Health provides an integration layer that connects third-party applications to electronic health record (EHR) systems, automatically triggering the relevant app at the right point in a clinical workflow and moving data securely between the EHR and apps. It targets EHR vendors and healthcare providers, offering a white-label app marketplace with HIPAA-compliant cloud or local deployment.

1 investor

Opal Therapeutics develops organoid models and therapies centered on female biology to improve drug discovery outcomes in women's health. The company addresses the underserved space of female-specific drug development by building human-relevant models that better capture female biological characteristics.

1 investor

OpenHealth provides a Lab Data API that harmonizes fragmented, heterogeneous lab results into a structured set of biomarkers and enriches them with medical context. It also offers modular white-label digital health reports and health wallets for patients and healthcare professionals in the health industry.

1 investor

Open Stent Solution develops a percutaneous medical device for mitral and tricuspid valve replacement in cardiac patients ineligible for open-heart surgery. The company leverages ribbon-based valve technology to enable less invasive treatment with smaller delivery systems adaptable to various valve sizes.

1 investor

OpenCall builds AI-powered call handling solutions that automate routine customer service interactions, freeing human agents to focus on complex issues and high-value work. The platform combines AI with human agents to reduce operational costs for customer-facing businesses.

1 investor

OpenClinica eConsent is a digital consent platform for clinical trials that enables participants to review and electronically sign informed consent forms using media-rich content on any device. It serves academic researchers, sponsors, contract research organizations (CROs), and clinical trial sites who need to streamline enrollment while maintaining regulatory compliance across decentralized, hybrid, and in-person studies.

1 investor

OpenCoreEMR develops flexible, intuitive electronic medical records software for healthcare providers to manage patient care with reduced administrative friction. The platform addresses shortcomings in legacy EMR systems by streamlining clinical workflows and improving data accessibility.

1 investor

OpenDR provides an AI-powered scheduling platform for radiology and medical imaging practices, letting patients self-schedule complex exams such as MRI, CT, and mammography online, by phone, or via a 24/7 AI agent. It integrates with practices' existing RIS systems to apply clinical rules, exam-specific logic, and automated reminders to reduce no-shows and manual data entry.

1 investor

Openface produces a two-step body acne treatment system combining an exfoliating shower gel and barrier-repair cream designed to address acne, keratosis pilaris, and uneven skin texture. The products are formulated for all skin types and manufactured in a GMP-certified facility in Germany.

1 investor

Open Health Technologies offers an API-based platform that harmonizes fragmented laboratory data into a standardized structure of biomarkers and enriches it with medical context. It serves patients, healthcare professionals, and businesses in the health industry, and provides white-label digital health reports and health wallets.

1 investor

OpenMarkets provides a platform that streamlines the purchase and sale of medical equipment for healthcare providers and suppliers through connected workflows and direct supplier access. The company serves healthcare organizations seeking to improve efficiency and reduce costs in equipment procurement and disposition.

1 investor

OpenNeuro (COSMIIC System) provides an open, FDA-tested neuromodulation hardware platform — including implantable devices, PCB designs, firmware, and regulatory documentation — that takes therapies from benchtop kits to animal-grade and human-grade implants for first-in-human studies. It serves neuromodulation researchers, biomedical engineers, and startups developing implantable therapies for conditions such as paralysis, chronic pain, incontinence, and autonomic disorders, with deployments across the US and Europe.

1 investor